Company: COPL-UN
Filing Date: 2025-04-14
Form Type: S-1/A
Source: 0001829126-25-002621
Chunk: 322

Company: Copley Acquisition Corp
Filing Date: 2025-04-14
Form: S-1/A
Chunk 322
---
, including the right to:

| ● | be informed about the purposes for which your personal data are processed; |

| ● | access your personal data; |

| ● | stop direct marketing; |

| ● | restrict the processing of your personal data; |

| ● | have incomplete or inaccurate personal data corrected; |

| ● | ask us to stop processing your personal data; |

| ● | be informed of a personal data breach (unless the breach is unlikely to be prejudicial to you); |

| ● | complain to the Cayman Islands’ Ombudsman; and |

| ● | require us to delete your personal data in some limited circumstances. |

If you consider that your personal data has not been handled correctly, or you are not satisfied with our responses to any requests you have made regarding the use of your personal data, you have the right to complain to the Cayman Islands’ Ombudsman. The Ombudsman can be contacted by email at info@ombudsman.ky or by accessing their website here: ombudsman.ky.

Certain Anti-Takeover Provisions of our Amended and Restated Memorandum and Articles of Association

Our authorized but unissued ordinary shares and preference shares are available for future issuances without shareholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved ordinary shares and preference shares could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

<div align='center'>196

SECURITIES ELIGIBLE FOR FUTURE SALE</div>

Immediately after this offering and the private placement we will have 20,667,143 (or 23,745,893 if the underwriter’s over-allotment option is exercised in full) ordinary shares outstanding. Of these shares, the 15,000,000 Class A ordinary shares (or 17,250,000 Class A ordinary shares if the underwriter’s over-allotment option is exercised in full) sold in this offering will be freely tradable without restriction or further registration under the Securities Act, except for any shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the outstanding founder shares (5,000,000 founder shares if the underwriter’s over-allotment option is not exercised and 5,750,000 founder shares if the underwriter